Physician, Sports Institute of Madrid (I.M.D.) - Sports Medicine @ Línea Madrid
Martin Pan's Education
Faculty of Pharmaceutical Medicine, London
Associate Member (Higher Medical Training in Pharmaceutical Medicine)
2006 - 2009
Universidad de Santiago de Compostela
MD (Degree in Medicine and Surgery)
1998 - 1998
GlaxoSmithKline R&D
Leadership Programme
2010 - 2011
Cardiff University / Prifysgol Caerdydd
PGCPM (Postgraduate Course in Pharmaceutical Medicine)
2006 - 2008
Universidad Complutense de Madrid
DEA (A with Honours, Doctoral Studies) (Pharmacology)
2000 - 2004
Ministerio de Educacion y Ciencia
Medical Specialist (Clinical Pharmacology and Therapeutics)
2000 - 2004
Martin Pan's Skills
Tuberculosis
Clinical Pharmacology
Drug Development
Medical Affairs
Global Health
Translational Medicine
Clinical Trials
Clinical Development
Infectious Diseases
Clinical Research
Martin Pan's Summary
Martin Pan, based in Switzerland, is currently a Executive Director, Global Medical Affairs - Alzheimer's Disease, Neurodegeneration at Eli Lilly and Company, bringing experience from previous roles at Amgen, Biogen, Otsuka Novel Products GmbH (Otsuka Pharmaceutical Companies) and GSK. Martin Pan holds a 2006 - 2009 Associate Member in Higher Medical Training in Pharmaceutical Medicine @ Faculty of Pharmaceutical Medicine, London. With a robust skill set that includes Tuberculosis, Clinical Pharmacology, Drug Development, Medical Affairs, Global Health and more, Martin Pan contributes valuable insights to the industry. Martin Pan has 2 emails and 1 mobile phone number on RocketReach.